Micah L. Berman, JD is the Executive Director of the Tobacco Public Policy Center at Capital University Law School. Responsible for the day-to-day operations of the center, Berman began his role Feb. 14, 2005. He previously worked as a trial attorney with the Antitrust Division of the U.S. Department of Justice and as an associate with the law firm of Stinson Morrison Hecker, LLP. Berman brings strengths in researching and investigating legal issues, as well as in collaborating with elected officials and policy makers.
Chris Bostic, JD, MS, is a Clinical Instructor with the Tobacco Control Clinic at the University of Maryland School of Law, where he focuses on global legal and technical assistance. Recent work with student attorneys has included research into the possibility of a "right to smoke" under foreign and international law, and on alternative livelihoods for tobacco farmers. Bostic also serves as Legal Counsel to the Framework Convention Alliance (FCA), a confederation of over 250 organizations from more than 100 countries dedicated to ending death and disease caused by tobacco. Bostic began his work in tobacco control during law school as a consultant for the Campaign for Tobacco-Free Kids during the ongoing negotiations for the Framework Convention on Tobacco Control. He has worked for the American Lung Association and Action on Smoking and Health, and is a founding member of the Tobacco Control Legal Consortium.
Kathleen Dachille, JD, is an Assistant Professor of Law and the Director of the Legal Resource Center for Tobacco Regulation, Litigation, and Advocacy. Because of her experience with policy and legislation in the Maryland General Assembly, Dachille also conducts a Maryland Legislative Practice Workshop. Dachille joined the faculty in 2002 after serving for eight years with the Office of the Attorney General of Maryland. During her tenure as an Assistant Attorney General, Dachille served in the Civil Litigation Division and the Opinions and Advice Division and as counsel to the Worker's Compensation Commission and counsel for election law. As a Special Assistant Attorney General, Dachille evaluated the proposed conversion of CareFirst BlueCross/BlueShield and designed the Attorney General's Program to Reduce Youth Access to Cigarettes.
Dr. Vera Luiza da Costa e Silva, MD, PhD, MBA, has coordinated different activities in the areas of epidemiology and cancer prevention and control at Brazil’s National Cancer Institute for 16 years. She has been involved in legislative, economic, surveillance, and regulatory tobacco control measures, the establishment of a country-wide tobacco control network, and the creation of a tobacco products regulatory authority in the country. Dr. Costa e Silva has also worked with cancer prevention, screening programs, and cancer registries activities in Brazil. During this period she has supported tobacco control programs in Latin American countries and other regions. From 2001 to 2005, Dr. Costa e Silva was the director of the Tobacco Free Initiative at the World Health Organization (WHO), in Geneva, Switzerland, where she supervised the secretariat to the negotiations of the WHO Framework Convention on Tobacco Control. She played an important role in global tobacco control activities, including coordinating global campaigns, tobacco product regulation initiatives, and capacity-building activities at country level in partnership with local governments. Dr Costa e Silva formerly worked as a senior public health consultant to Brazil’s government and to international organizations in 2006 and 2007. She is currently working as a technical officer at the Pan American Health Organization, and is based in Washington, D.C.
Richard A. Daynard, JD, MA, PhD, is Professor of Law at Northeastern University School of Law, where he has been teaching since 1969. His current responsibilities are in the area of Public Health Law and Law, Policy and Society. Professor Daynard has been Chair of the Tobacco Products Liability Project since its inception in 1984, has presided over more than 20 national and international conferences on tobacco liability issues, and edited the Tobacco Products Litigation Reporter from 1985 to 2006. He is currently Principal Investigator of an NCI-funded RO1 grant on “The Influence of the Legal Environment on the Tobacco Industry.” Daynard has written over 80 articles on issues related to tobacco litigation, and has spoken about them in over 35 countries. He is currently President of the Public Health Advocacy Institute, successor to the Tobacco Control Resource Center. Daynard is a Board Member of the Framework Convention Alliance (FCA), and worked with the FCA during drafting of the Framework Convention on Tobacco Control to ensure inclusion of provisions supporting litigation as a tobacco control strategy.
William T. Godshall, MPH,founded SmokeFree Pennsylvania in 1990, and has been its executive director since. SmokeFree Pennsylvania has successfully advocated policies for smokefree air, reducing tobacco marketing to youth, increasing tobacco taxes, and expanding nicotine addiction treatment services. SmokeFree Pennsylvania has exposed and opposed numerous tobacco industry protection policies, programs, front groups, coalitions, lobbyists and politicians. Originally a statewide grass roots organization, SmokeFree Pennsylvania has also been involved in numerous national level activities. Bill Godshall maintains an e-mail list (via Smokescreen.org) with 11,000 health advocates, as well as an interactive listserve that includes more than 100 of the nation's leading activists.
Cheryl Healton, MPA, PhD, joined the American Legacy Foundation in 1999, a groundbreaking public health nonprofit created by the historic Master Settlement Agreement between 46 state attorneys general, five U.S. territories and the tobacco industry. Dr. Healton has worked tirelessly to further the foundation’s ambitious mission: to build a world where young people reject tobacco and anyone can quit. During her tenure with the foundation, she has guided the highly acclaimed, national youth tobacco prevention counter-marketing campaign, truth®, that has been credited in part with reducing youth smoking prevalence to its current 28-year low. Although her current focus is aimed at reducing the deadly toll of tobacco on Americans, Dr. Healton‘s long and dynamic career in the field of public health has earned her national recognition and praise. The recipient of numerous prestigious awards, she has been honored recently with the Social Justice Award from the State of Hawaii and received the American Lung Association’s Life and Breath Award in 2003.
Diane Hoffmann, JD, MS, has been on the faculty at Maryland since 1987. Her research interests include issues at the intersection of law, health care, ethics and public policy such as advance directives, pain treatment, termination of life support, genetics, regulation of research, and of managed care. She was a primary author of Maryland's Health Care Decisions Act dealing with advance directives, surrogate decision-making and guardianship for individuals lacking health care decision-making capacity. She has served as a member of a number of ethics committees including those at University of Maryland Medical Systems, the National Institutes of Health in Bethesda, and the VA Medical Center in Baltimore and is author of A Handbook for Nursing Home Ethics Committees published by the American Association of Homes & Services for the Aging (AAHSA).
Dr. Peter G. Shields is the Associate Director for Cancer Control and Population Sciences in the Lombardi Comprehensive Cancer Center, and the Director of the Division of Cancer Genetics and Epidemiology in the Department of Oncology. Dr. Shields also holds an appointment as a Professor in the Department of Pediatrics and Child Health at Howard University Hospital. Dr. Shields' research focuses on gene-environment interactions for cancer risk, with a strong emphasis on tobacco-related harm and also separately on breast cancer. The laboratory component of his research develops new biomarkers of cancer risk, while his epidemiological work studies special populations and tests hypotheses related to determining the causes of cancer.
David Sweanor, JD, is an Adjunct Professor, Faculty of Law and Faculty of Medicine, at the University of Ottawa. Sweanor has worked full time in global public health efforts on tobacco for nearly a quarter of a century. He has played a key role in Canadian efforts on tobacco taxation, smuggling, advertising restrictions, package labeling, environmental tobacco smoke, cessation, and product regulation. He has also been active on a similar range of global issues, working with bodies such as the International Union Against Cancer, World Health Organization, and the World Bank. Sweanor’s travels have taken him to roughly 70 countries. Among his honors is a "Public Health Hero" award for lifetime achievement from the Pan-American Health Organization. Sweanor’s primary area of work has been the interaction of law and economics as a determinant of public health, with particular recent emphasis on tax policy, contraband tobacco, the provision of tobacco dependence treatment products, and the changing landscape of "harm reduction" products. He has a strong background in business and finance and has long studied the dynamics of the tobacco industry.
Geoffrey Ferris Wayne is the research manager for the Tobacco Control Research and Training Program at the Harvard School of Public Health. His primary areas of expertise include industry use and manipulation of product additives, tobacco smoke constituents and smoke chemistry; use of product changes to target smoker groups and needs; and effects of product design on sensory perception, smoker behavior, smoke delivery and uptake. He has had extensive experience with internal tobacco industry documents as well as industry trial testimony since they first became available through litigation. Mr. Ferris Wayne worked from 1997-2004 in the Massachusetts Department of Public Health focusing on issues of tobacco product design and regulation, particularly nicotine and ingredient disclosure. He has also served in an advisory capacity to the World Health Organization on product design and additives.
Mitch Zeller, JD, is Vice President for Policy and Strategic Communications, PinneyAssociates, and Instructor, Harvard School of Public Health. Zeller has more than 25 years of regulatory, legislative, and communications experience working with federal health agencies on public health policy issues, including the treatment of tobacco dependence and the regulation of tobacco products and pharmaceuticals. He was formerly executive vice president of the American Legacy Foundation (ALF), where his responsibilities included marketing, communications, and strategic partnerships. In January 2002, Zeller created ALF's first Office of Policy and Government Relations. From 1993 until June 2000, Zeller served as associate commissioner and director of the Food and Drug Administration's (FDA’s) Office of Tobacco Programs, where he built the first nationwide program to reduce youth access to tobacco. Zeller also served as an official U.S. delegate to the World Health Organization (WHO) Working Group for the Framework Convention on Tobacco Control. Zeller has won many awards for his work on tobacco, including the Secretary's Award for Distinguished Service and the National Public Affairs Special Recognition Award from the American Heart Association. He also had the honor of being selected to travel to Moscow to accept the "World No Tobacco Day" medal from the WHO President in recognition of the Clinton Administration's groundbreaking work on tobacco.